Celltrion’s Covid-19 antibody therapy approved in South Korea
CT-P59 marks the first monoclonal antibody to receive full approval from Korean MFDS to treat patients with Covid-19
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Sep 21
CT-P59 marks the first monoclonal antibody to receive full approval from Korean MFDS to treat patients with Covid-19
17 Sep 21
Under the agreement, BBL will get access to 100 million doses of vaccines per annum for 15 years,…
17 Sep 21
Health Canada approved the Moderna’s NDS-CV based on clinical data from the Phase 3 COVE study in more…
16 Sep 21
The US FDA has simultaneously approved Thermo Fisher Scientific’s NGS CDx to identify NSCLC patients eligible for treatment…
16 Sep 21
The country is focusing more on building expertise in mRNA vaccines and viral vector shots
15 Sep 21
The biotechnology company will supply additional 1.4 million 1,200mg doses of REGEN-COV to the US government, at a…
15 Sep 21
The Indian study was conducted to determine IgG antibody among health care workers with completed vaccine dose
14 Sep 21
Regenxbio will receive an upfront payment of $370m, along with an additional up to $1.38bn in potential milestone…
14 Sep 21
The data was based on Phase 3 EBOVAC-Salone clinical study, in which the vaccine regimen was well-tolerated in…
13 Sep 21
Cibinqo (abrocitinib) is a once-daily oral JAK1 inhibitor indicated for the treatment of moderate to severe atopic dermatitis…